Searched for
PHARMA IPO NEWS
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...- IPO investors brace for 73 lock-in expiries worth $34 billion in three months. Will your portfolio be impacted?India’s stock market is set for a wave of IPO lock-in expiries over the next three months, with shares worth $34 billion from 73 recently l...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Akums Drugs & Pharma IPO share allotment to be finalised today: Check status, GMP, listing date and other detailsAkums Drugs & Pharma share allotment has been finalised. Shares will be out on August 6. The IPO was subscribed 63.5 times. Proceeds will a...
- Akums Drugs and Pharma IPO opens for subscription. Should you bid?Akums Drugs IPO Review GMP, Subs: Akums Drugs and Pharmaceuticals' IPO, valued at Rs 1,857 crore, closed on August 1. The issue included Rs...
- Akums Drugs and Pharma IPO: Co to raise ₹1,857 crore at price band of Rs 646-679/share; issue opens on July 30Akums Drugs and Pharma IPO: Akum Drugs and Pharmaceuticals set a price band of Rs 646 to Rs 679 per share for its IPO, aiming to raise Rs 1...
- Emcure Pharma IPO GMP: Street anticipates a robust listing tomorrow. Will it trump expectations?Emcure Pharmaceuticals' shares to debut on stock exchanges with a GMP of Rs 360. Analysts bullish on both short-term and long-term gains. C...
- Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPOShark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the up...
- Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
- Looking for anti-consensus ideas? Jyotivardhan Jaipuria says only 2 sectors left“Pharma had been going through bad times for the last 18 months in terms of stock price. Earnings were not that great but will turn around ...
- Mankind Pharma IPO sails through on Day 3Around nine brokerages have given "subscribe" recommendations on the issue, with some of them seeing the potential in the long term. Analys...
- Mankind Pharma IPO subscribed 32% so far on Day 2. Check GMP and other details.Mankind Pharma's initial public offering (IPO), which will close on January 19, has been subscribed by 32% on Day 2 with non-institutional ...
- Mankind Pharma IPO opens for subscription today: Should you bid?Indian pharma giant Mankind Pharma has launched its initial public offering (IPO), with around 40 million equity shares available for sale....
- Mankind Pharma IPO opens on Tuesday. What GMP suggests for potential investors?The company has fixed a price band of Rs 1,026-1,080 for its IPO, which is completely an offer for sale (OFS) of 40 million equity shares b...
- Mankind Pharma IPO: 10 things to know about the biggest issue so far this yearIndian pharma company Mankind Pharma is set to open its IPO next week. The offer for sale of 40 million equity shares by promoters and othe...
- Mankind Pharma sets IPO price band at Rs 1,026-1,080The IPO is entirely an offer for sale (OFS) by promoters and existing investors who are looking to divest their stakes in the Delhi-based p...
- Mankind Pharma IPO to open for subscription on April 25The company has hired Kotak Investment Banking, Axis Capital, IIFL Securities, Jefferies and JP Morgan as book-running lead managers while ...
- Mankind Pharma files DRHP for Rs 5,500 crore IPOThe company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...
- Gland Pharma’s Rs 6,480 crore IPO sails through, gets 2.06x bidsProgressive Share Brokers said that sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that S...
- Gland Pharma IPO: Analysts recommend subscribing, but flag stretched valuationsGland Pharma’s IPO is India’s largest pharmaceutical IPO ever.
Load More
